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Hb E/b thalassemia is the most common b thalassemia
syndrome in Asia-Pacific due to a high prevalent of Hb E
and b thalassemia genes. Management of this condition
can be cumbersome due to its clinical heterogeneity and
various disease severity ranging from severe end in which
patients are transfusion dependent thalassemia (TD)
similar to that of b thalassemia major (TM) to moderate
and mild severity which are non-transfusion dependent
thalassemia (NTDT) akin to b thalassemia intermedia.
Although, clinical diagnosis of Hb E/b thalassemia might
be identical, the natural history and disease related com-
plications can vary greatly due to different baseline sever-
ity and management received. In this study, we evaluated
vitamin D deficiency, one of the most common endocrine
complications described in TM, in Thai HbE/b thalasse-
mia children who were TD and NTDT.
109 children aged 5.9 to 14.1 years with HbE/b-
thalassemia were enrolled. 60 patients who received no or
occasional transfusion were classified into NTDT group.
While 49 patients who received regular transfusion every
3 weeks to keep pre-transfusion Hb at 9-10 g/dL were
classified into TD group. All TD patients except two
received iron chelation. Blood samples were collected to
determine hemoglobin, serum ferritin and 25-OHD levels.
Mean Hb of NTDT was lower than TD patients
(8.1+1.0 vs. 10.0+1.0 g/dL, P<0.001). In contrast, TD
had higher mean serum ferritin than NTDT patients
(4104+2336 vs. 347+488 ng/mL, P<0.001). However,
mean serum 25-OHD of NTDT was lower than in
TDT patients (22.7+5.2 vs. 25.0+6.1 ng/mL, P=0.043).
Moreover, the percentage of patients who were vitamin
D deficient (serum 25-OHD < 20 ng/mL) in NTDT
was higher than TD patients (33.3% vs. 12.2%, P=0.01).
We found no correlation between serum 25-OHD vs.
ferritin and Hb levels.
Although patients with HbE/b thalassemia do not
require regular blood transfusion due to their ‘milder’
clinical severity, they remain at high risk of having vita-
min D deficiency. A better standard of care for these
neglected patients is in an urgent need and a regular
monitoring of serum 25-OHD with adequate vitamin D
supplementation for deficient patients is highly recom-
mended for all Hb E/b thalassemia regardless of their
clinical severity.
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